A 5.5-year study found that stressful events and low social support accelerate HIV progression to AIDS, with men who developed AIDS twice as likely to have experienced major depressions before onset.
The American Psychiatric Association is establishing the first comprehensive guidelines for treating persons with HIV infection and AIDS. The new guidelines will focus on access to care, treatment adherence, education, prevention, and direct mental health services.
A DNA vaccine developed by Emory University researchers protects monkeys against HIV challenge infections, demonstrating a promising step towards an effective AIDS vaccine. The vaccine uses a two-step approach, priming the immune system with a DNA vaccine and followed by booster immunizations with a pox virus.
Researchers found a significant link between HIV infections and abnormal vaginal bacteria in pregnant women. Four times as many subjects with bacterial vaginosis were HIV-infected compared to those with a normal balance.
Researchers discovered that lysozyme, a protein abundant in tears, is also present in the urine of pregnant women and acts as a potent anti-HIV agent. Additionally, ribonucleases were identified in the urine, breaking apart viral RNA and potentially inhibiting HIV replication.
Researchers found that intense stimulation is required to create lasting memory T cells, which are crucial for killing HIV-infected or cancerous cells. This discovery may provide a solution to vaccine challenges in treating AIDS and cancer.
Researchers at Advanced Viral Research Corp. discovered that Reticulose markedly decreases the production of CCR5 receptors in CD4 positive T-lymphocytes, increasing resistance to HIV infection. This finding may enhance the effectiveness of AIDS cocktails and pave the way for combination therapy.
Researchers are exposing chimps to lethal HIV strains to develop an AIDS vaccine, with some arguing that the practice is unjustified and disrespects animal life. Chimps have already been infected with deadly strains of HIV, and more may be exposed in future experiments.
Research reveals that the AIDS virus in cerebrospinal fluid evolves independently of the virus in the blood, leading to two genetically distinct forms. This finding suggests that drugs effective against HIV-1 in blood may not be effective in the central nervous system, and vice versa.
A study reveals a dramatic rise in oral warts among HIV patients treated with protease inhibitors, which are effective against HIV. The researchers found that these warts were difficult to control and highly prone to recurrence, causing discomfort and affecting eating habits.
A study by Emory University infectious disease specialists found that most inner-city HIV patients hospitalized for HIV or AIDS had not received outpatient care or HAART therapy in six months prior. Despite the effectiveness of combination drug therapy, patients often fail to take advantage of available resources.
Researchers identified a subspecies of chimpanzees as the natural reservoir of HIV-1, leading to cross-species transmission events. Studying these animals may help protect humans from developing AIDS.
University of Illinois researcher Paula Treichler argues that popular culture and narrative can effectively engage the public about science. The AIDS storyline on ABC's General Hospital is cited as an example of this approach, which used a soap opera format to educate and explore the meanings of AIDS.
Luis Montaner, a Wistar Institute scientist, has been awarded a $79,000 grant to support his HIV-1 Patient Partnership for Basic Research project. The project aims to find new treatments and develop vaccines for human immunodeficiency virus (HIV-1) through medical research.
Scientists from the University of Montana and HHMI successfully produced broadly effective antibodies against HIV by capturing the virus's infective machinery in the moment it fuses with a target cell. The new approach outperforms previous efforts, which only neutralized laboratory-grown strains.
A UK allied health professor has received a patent to test the effectiveness of combining lithium salts with existing anti-viral drug agents for AIDS patients. The proposed treatment aims to reduce toxic side effects and enhance the immune system, potentially reducing the amount of virus in the body.
Researchers found HIV's impact on T-cell production and its role in the immune system. The study involved measuring daily rates of new T-cell production in HIV-negative adults and those with suppressed virus, revealing a surprising increase in new cell production responsible for increased T-cell counts.
Researchers suggest that genetic remnants of an ancient virus incorporated into human DNA may assist the AIDS virus in evading anti-drug treatments. Studies found that a specific enzyme from this endogenous virus gene can complement HIV-1 protease activity, making it resistant to current drugs.
Researchers propose that HIV's passive infection of astrocytes may contribute to AIDS dementia by disrupting glutamate removal. The study found more apoptotic astrocytes in brains of people with dementia compared to those without, suggesting a potential new target for prevention and treatment.
BioStratum's gene-attenuated virus vaccines protect macaque monkeys against HIV-1-based viruses. The study demonstrates the efficacy of two vaccines in preventing AIDS development in 11 out of 12 monkeys.
The number of newborns infected with HIV has decreased significantly thanks to optimal anti-retroviral treatment for mothers, while the number of surviving HIV-infected children has risen. Early aggressive therapy, teamwork, and a holistic approach are key to keeping children well with HIV.
Researchers from the University of Michigan, Northwestern University, University of Minnesota, and University of Wisconsin have formed a virtual center to facilitate collaboration. This innovation uses collaborative tools and technology to enable researchers to work together as if they were in the same location.
A peer-led intervention program, EachOne TeachOne, has shown success in reducing high-risk behaviors among drug users, with 80% of participants cutting back on their drug use or maintaining a low level of risk. However, condom use remained an area of concern, with only 25% of participants showing improvements.
The Pan American Health Organization reports progress in controlling poliomyelitis, measles outbreaks, and Chagas' disease. The region has also seen a decline in cholera cases, with only 5% of reported cases in 1997 compared to six years earlier.
Jay A. Levy, a UCSF professor of medicine, suggests delaying antiviral therapy for HIV infection until the CD-4 cell count falls below 400 and the viral load is above 30,000 copies per milliliter. This approach aims to avoid drug resistance and allow the immune system to recover and control the virus.
A recent trial found that patients with HIV-related sensory neuropathy experienced significantly lessened pain intensity and improved sensation after receiving injections of lab-created nerve growth factor. The study also identified which nerves are involved in the injury, paving the way for future research on regrowing damaged nerves.
Scientists identify a new pathway through which HIV can disturb the function of uninfected cells, leading to a sudden decline in immune function. The research suggests that blocking HIV binding to CXCR4 could stop advanced AIDS progression in patients with certain strains of the virus.
The UCSF Center for AIDS Research has been awarded a major grant from the National Institutes of Health to support ongoing work in basic, clinical, and behavioral science areas of HIV/AIDS. The grant will focus on developing new treatment approaches, understanding HIV transmission, and improving therapy effectiveness.
The Emory/Atlanta CFAR is a multidisciplinary research center focusing on the prevention and treatment of HIV/AIDS. With a $2.3 million grant, it aims to foster collaboration among diverse HIV/AIDS programs in Atlanta.
Researchers at UCSF found that patients with HIV who undergo aggressive therapy have a robust response to cytomegalovirus, which causes blindness in people with AIDS. This suggests that CD4+ T cells replenished by therapy can mount effective responses against specific pathogens.
Research participants advocate for full disclosure of experimental vaccine details, physical and social harm reduction, and community collaboration. They also want assurance of compensation, confidentiality, and support in case of adverse reactions.
A new study by University of California San Francisco researchers proposes expanding federal Medicaid coverage of HIV drugs to control the disease. The expansion would result in 9,600 more years of life for persons with HIV disease over five-years and prevent 4,200 deaths.
A team of researchers documented a case of transmission of protease-resistant HIV, which is resistant to six of the 11 approved HIV anti-retroviral drugs. The patient was infected through unprotected anal intercourse with a partner who had previously been treated with these drugs, highlighting the need for continued prevention efforts.
A recent study published in Annals of Internal Medicine found that testosterone administration significantly increases lean body mass and improves the quality of life in men with AIDS wasting syndrome. The treatment was shown to produce significant term benefits, making it an important new therapy for patients with this condition.
A study found that 56% of HIV-infected gay men in the US are using combination therapy, but many are delaying treatment due to concerns about commitment and side effects. The study showed a strong link between advanced HIV infection and use of combination therapy.
Anemia is a major cause of debilitating fatigue and early death in people with HIV. Research shows that treating anemia can reduce the risk of mortality, especially when related to antiretroviral therapy like AZT.
Researchers found that 11% of infected men were long-term nonprogressors at 10 years, but only 2% remained nonprogressors after 18 years. High plasma viral loads are a strong predictor of disease progression. Antiviral therapy is recommended for individuals with rising virus levels and high CD4 counts.
A San Francisco study found that 55% of HIV patients who achieved undetectable viral levels experienced a return to detectability within one year, yet remained generally healthy. The study's findings suggest that maintaining undetectable viral load levels may not be necessary for sustaining wellness.
University of Pittsburgh researchers discover that boosting CD8 T cells, also known as killer T cells, can establish long-term immunity against HIV-1. By treating dendritic cells with HIV-1 proteins and interleukin-12, the immune system can be trained to recognize and attack infected cells.
Researchers have developed a new strategy to determine the early stages of HIV infection, allowing for targeted treatment and study. The approach uses a modified enzyme immunoassay test to distinguish between recent and long-term infections, enabling more precise diagnosis and monitoring of disease spread.
The updated guidelines advocate for early, potent combination antiretroviral therapies to prevent AIDS in individuals infected with HIV. The new recommendations suggest that simpler drug regimens may offer greater compliance and convenience.
The international panel emphasizes that blood tests measuring HIV levels and CD4 cells should guide treatment decisions, rather than resistance testing. The panel also highlights the limitations of current resistance assays and recommends further epidemiological studies to monitor resistant strain prevalence.
A study by INFORMS shows that introducing difficult-to-reuse syringes, also known as DTRs, into the current needle population does not reduce HIV rates among addicts. In fact, it increases the risk of exposure to infectious needles due to increased reuse of regular syringes.
A major HIV prevention trial involving low-income women and men living in urban areas found that behavioral interventions can reduce HIV-related sexual risk. The study, which recruited 3,700 participants, showed significant improvements in condom use and reductions in unprotected sexual acts after a one-year intervention.
Macrophages may proliferate in response to HIV integration, causing disease through sequential pathogenesis. Researchers identify potential DNA-interacting drugs to treat AIDS dementia.
A free orientation program developed by UF professor Alice Holmes aims to increase patient satisfaction among hearing aid users. The four-session program provides realistic guidance on using hearing aids, adjusting settings, and preventing communication breakdowns.
A new study found that social disruption in monkeys infected with simian AIDS virus accelerates disease progression. Monkeys separated from familiar companions experienced faster development of AIDS, highlighting the impact of psychosocial factors on immunodeficiency disease.
A two-year study on the effects of marijuana in HIV patients is underway, examining its impact on the immune system, virus levels, and interactions with antiviral drugs. The trial, which began last week, will enroll 63 patients over 18 months to assess the safety of THC for HIV/AIDS treatment.
A new study by researchers at UCSF AIDS Research Institute found that a short-course of antiviral drug therapy and high prevalence of HIV-positive women of child-bearing age can produce a cost-effective outcome. If drug prices are lowered to 25% of the industrialized world cost, treatment for 100 women could cost around $1,014.
William E. Paul, a prominent NIH AIDS researcher, has been awarded the 1998 Abbott Laboratories Award in Clinical and Diagnostic Immunology. He made significant contributions to understanding cytokine biology, T-cell reproduction, and B-cell activation.
Researchers discovered that syphilis increases HIV transmission by activating immune cells through bacterial membrane lipoproteins. This understanding could lead to treatments to slow HIV disease progression. The study found a plausible molecular explanation for why people with syphilis are more likely to transmit or contract HIV.
Researchers have created a laboratory model of AIDS by infecting tonsil tissue with HIV. The model reveals that changes in the virus's properties lead to immune system deterioration and supports the idea that environmental factors contribute to AIDS development.
Researchers found a significant association between clinic experience and survival of women with AIDS, with 71% of patients in high-experience clinics surviving 21 months after diagnosis. The study suggests that physicians who treat a certain illness more frequently may do it better, especially in HIV management.
A novel diagnostic technique uses isotope mass spectrometry to measure T cell proliferation rates in AIDS patients, allowing physicians to establish the proper time for medication and optimal treatment. The technology holds promise for optimizing AIDS therapy and diagnosing other conditions.
Researchers at UC Berkeley and UC San Francisco have developed a diagnostic technique that measures T-cell production rates in patients with AIDS. The study found that potent protease inhibitor treatments can increase T-cell production, suggesting new treatment options for patients.
Researchers have developed a new diagnostic technique to measure T cell proliferation rates in AIDS patients, revealing that the body's capacity to form new cells is key to T cell counts. The technique allows for personalized treatment optimization and real-time disease monitoring.
Scientists have determined the 3D molecular structure of HIV's nucleocapsid protein, which recognizes and binds to viral RNA. This discovery may lead to the development of highly specific anti-AIDS drugs that can prevent HIV spread and be safe for patients.
A study published in the Journal of the American Medical Association found that certain symptoms like fever, joint pain, and night sweats can identify people with recent HIV infection before a positive blood test. The researchers screened over 3,800 patients and found that those with these symptoms were more likely to have the virus.
Recent studies have identified key risk factors and clinical symptoms associated with acute HIV infection in India, particularly among commercial sex workers. The findings highlight the importance of p24 antigen screening to detect infections early, reducing the accuracy of previously described signs and symptoms., Condom distribution ...
A national survey by MTV and Yale University finds that nearly 9 out of 10 young people (87%) believe they are invulnerable to getting the AIDS virus, despite high-risk behaviors such as unprotected sex. The study highlights a need for accurate health information and education, particularly among marginalized groups.